148 related articles for article (PubMed ID: 28985870)
1. Polymeric micelles loaded with (1,2-diaminocyclohexane)platinum(II) against colorectal cancer.
Nirei T; Ishihara S; Tanaka T; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Watanabe T
J Surg Res; 2017 Oct; 218():334-340. PubMed ID: 28985870
[TBL] [Abstract][Full Text] [Related]
2. Optimization of (1,2-diamino-cyclohexane)platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity.
Cabral H; Nishiyama N; Kataoka K
J Control Release; 2007 Aug; 121(3):146-55. PubMed ID: 17628162
[TBL] [Abstract][Full Text] [Related]
3. cRGD-installed polymeric micelles loading platinum anticancer drugs enable cooperative treatment against lymph node metastasis.
Makino J; Cabral H; Miura Y; Matsumoto Y; Wang M; Kinoh H; Mochida Y; Nishiyama N; Kataoka K
J Control Release; 2015 Dec; 220(Pt B):783-91. PubMed ID: 26474676
[TBL] [Abstract][Full Text] [Related]
4. Preparation and biological properties of dichloro(1,2-diaminocyclohexane)platinum(II) (DACHPt)-loaded polymeric micelles.
Cabral H; Nishiyama N; Okazaki S; Koyama H; Kataoka K
J Control Release; 2005 Jan; 101(1-3):223-32. PubMed ID: 15588907
[TBL] [Abstract][Full Text] [Related]
5. Polymeric micelles loaded with platinum anticancer drugs target preangiogenic micrometastatic niches associated with inflammation.
Wu H; Cabral H; Toh K; Mi P; Chen YC; Matsumoto Y; Yamada N; Liu X; Kinoh H; Miura Y; Kano MR; Nishihara H; Nishiyama N; Kataoka K
J Control Release; 2014 Sep; 189():1-10. PubMed ID: 24956488
[TBL] [Abstract][Full Text] [Related]
6. Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis.
Rafi M; Cabral H; Kano MR; Mi P; Iwata C; Yashiro M; Hirakawa K; Miyazono K; Nishiyama N; Kataoka K
J Control Release; 2012 Apr; 159(2):189-96. PubMed ID: 22326402
[TBL] [Abstract][Full Text] [Related]
7. MRI-detectable polymeric micelles incorporating platinum anticancer drugs enhance survival in an advanced hepatocellular carcinoma model.
Vinh NQ; Naka S; Cabral H; Murayama H; Kaida S; Kataoka K; Morikawa S; Tani T
Int J Nanomedicine; 2015; 10():4137-47. PubMed ID: 26203241
[TBL] [Abstract][Full Text] [Related]
8. Assessment of antitumor activity and acute peripheral neuropathy of 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016).
Ueno T; Endo K; Hori K; Ozaki N; Tsuji A; Kondo S; Wakisaka N; Murono S; Kataoka K; Kato Y; Yoshizaki T
Int J Nanomedicine; 2014; 9():3005-12. PubMed ID: 24971011
[TBL] [Abstract][Full Text] [Related]
9. Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting.
Murakami M; Cabral H; Matsumoto Y; Wu S; Kano MR; Yamori T; Nishiyama N; Kataoka K
Sci Transl Med; 2011 Jan; 3(64):64ra2. PubMed ID: 21209412
[TBL] [Abstract][Full Text] [Related]
10. Bioinspired hyaluronic acid and polyarginine nanoparticles for DACHPt delivery.
Matha K; Lollo G; Taurino G; Respaud R; Marigo I; Shariati M; Bussolati O; Vermeulen A; Remaut K; Benoit JP
Eur J Pharm Biopharm; 2020 May; 150():1-13. PubMed ID: 32113915
[TBL] [Abstract][Full Text] [Related]
11. Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) on a human gastric cancer model.
Yamamoto Y; Hyodo I; Takigahira M; Koga Y; Yasunaga M; Harada M; Hayashi T; Kato Y; Matsumura Y
Int J Cancer; 2014 Jul; 135(1):214-23. PubMed ID: 24353132
[TBL] [Abstract][Full Text] [Related]
12. Speciation of oxaliplatin adducts with DNA nucleotides.
Zayed A; Jones GD; Reid HJ; Shoeib T; Taylor SE; Thomas AL; Wood JP; Sharp BL
Metallomics; 2011 Oct; 3(10):991-1000. PubMed ID: 21858382
[TBL] [Abstract][Full Text] [Related]
13. Preclinical efficacy and pharmacokinetics of AP5346, a novel diaminocyclohexane-platinum tumor-targeting drug delivery system.
Rice JR; Gerberich JL; Nowotnik DP; Howell SB
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2248-54. PubMed ID: 16609041
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy.
Zhang B; Wang T; Yang S; Xiao Y; Song Y; Zhang N; Garg S
J Control Release; 2016 Sep; 238():10-21. PubMed ID: 27432750
[TBL] [Abstract][Full Text] [Related]
15. Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen.
André T; Bensmaine MA; Louvet C; François E; Lucas V; Desseigne F; Beerblock K; Bouché O; Carola E; Merrouche Y; Morvan F; Dupont-André G; de Gramont A
J Clin Oncol; 1999 Nov; 17(11):3560-8. PubMed ID: 10550155
[TBL] [Abstract][Full Text] [Related]
16. Preparation and In Vivo Evaluation of Dichloro(1,2-Diaminocyclohexane)platinum(II)-Loaded Core Cross-Linked Polymer Micelles.
Oberoi HS; Nukolova NV; Zhao Y; Cohen SM; Kabanov AV; Bronich TK
Chemother Res Pract; 2012; 2012():905796. PubMed ID: 22844591
[TBL] [Abstract][Full Text] [Related]
17. Pharmacology of oxaliplatin in solid tumor patients with hepatic dysfunction: a preliminary report of the National Cancer Institute Organ Dysfunction Working Group.
Doroshow JH; Synold TW; Gandara D; Mani S; Remick SC; Mulkerin D; Hamilton A; Sharma S; Ramanathan RK; Lenz HJ; Graham M; Longmate J; Takimoto CH; Ivy P
Semin Oncol; 2003 Aug; 30(4 Suppl 15):14-9. PubMed ID: 14523790
[TBL] [Abstract][Full Text] [Related]
18. Polymeric micelles for targeted tumor therapy of platinum anticancer drugs.
Mochida Y; Cabral H; Kataoka K
Expert Opin Drug Deliv; 2017 Dec; 14(12):1423-1438. PubMed ID: 28290714
[TBL] [Abstract][Full Text] [Related]
19. Selective delivery of oxaliplatin to tumor tissue by nanocarrier system enhances overall therapeutic efficacy of the encapsulated oxaliplatin.
Lila AS; Kiwada H; Ishida T
Biol Pharm Bull; 2014; 37(2):206-11. PubMed ID: 24492717
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies.
Culy CR; Clemett D; Wiseman LR
Drugs; 2000 Oct; 60(4):895-924. PubMed ID: 11085200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
